Biren Amin's Stock Ratings

Piper Sandler Analyst

Biren Amin is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

-2.87%

Smart Score

49.3%

Overall Average Return Percentile

32nd

Number of Ratings

11
Buy NowGet Alert
06/27/2024CRGXBuy Now
Cargo Therapeutics
$16.42125.33% → $37Initiates → OverweightGet Alert
06/21/2024SLDBBuy Now
Solid Biosciences
$5.75247.83%$20 → $20ReiteratesOverweight → OverweightGet Alert
06/21/2024OCULBuy Now
Ocular Therapeutix
$6.84119.3%$15 → $15MaintainsOverweightGet Alert
06/21/2024SRPTBuy Now
Sarepta Therapeutics
$158.00-0.63%$157 → $157MaintainsOverweightGet Alert
05/31/2024SRPTBuy Now
Sarepta Therapeutics
$158.00-0.63% → $157Initiates → OverweightGet Alert
05/31/2024IMNMBuy Now
Immunome
$12.05124.07% → $27Initiates → OverweightGet Alert
05/31/2024ELEVBuy Now
Elevation Oncology
$2.66275.94% → $10Initiates → OverweightGet Alert
05/31/2024APLSBuy Now
Apellis Pharmaceuticals
$38.9018.25% → $46Initiates → NeutralGet Alert
05/31/2024ALLOBuy Now
Allogene Therapeutics
$2.33372.1% → $11Initiates → OverweightGet Alert
05/31/2024ACLXBuy Now
Arcellx
$55.1926.83% → $70Initiates → OverweightGet Alert
05/19/2023ZNTLBuy Now
Zentalis Pharma
$4.091611.49%$120 → $70MaintainsBuyGet Alert